Cleveland Clinic Abu Dhabi first to use new tools for safe brain aneurysm treatment in the first area. world News

The Cleveland Clinic Abu Dhabi has become the first hospital in the Middle East and North Africa region, deploying Artis Intracular Flow Modulator, which is a state -of -the -art device for the treatment of wide -neck brain arterirs. Health Department – As a specified center of excellence for stroke by Abu Dhabi, the hospital continues to commit its commitment to pursue minimum invasive neurological care, providing more effective options for traditional brain surgery.

A success in aneurism treatment

Cleveland Clinic Abu Dhabi has launched a novel progress in neurovascular care with the adoption of Artis Intracular Flow Modulator, designed to treat a special transplant as a special transplant to treat wide -necked intrachrinel aneurysm. This technique represents a new standard in stroke treatment in the MNA region. Cerebral aneurysm, which is often referred to as strokes in broad words, when a weak section of the brain blood vessel spreads or expands the balloon. If left untreated, they pose a high risk of rupture and can be sabarachanoid hemorrhage in the form of life-drugs of brain bleeding. Traditionally, treatment included invasive open brain surgery. However, new approaches are moving towards minimal invasive techniques, the patient’s risk is significantly reduced and improving long -term results. Artis device, unlike older methods, usually requires several coils or filaments, using a single complex design mesh structure that is directly deployed in the aneurysm. This device fills the aneurysmal sac, blocks blood flow in it and permanently closes it from the circulation of the brain. It remains in place for life, eliminating the need for follow -up surgery. This process begins with a catheter-based access, usually through the brain or hand, to reach the affected vessel in the brain. Using advanced 3D imaging and angiography, doctors keep the device with accuracy. Depending on the complexity, the process can take between two to eight hours. Post-operative follow-ups are important; Imaging is usually conducted in three and six months to ensure a complete obstruction of aneurysm. The first patient treated with Artis device in Cleveland Clinic Abu Dhabi showed successful aneurysm in his three-month follow-up, which confirms the medical capacity of the device.

Leading in special neurological care

The neurological institute of Cleveland Clinic Abu Dhabi has long adopted a multi -compound model of care, including expertise of experts in neurosurgery, interventional neuroradiology and neurology. This approach ensures that patients receive individual treatment plans, guided by the latest imaging and catheter-based innovations. Dr. According to Khalil Zahra, Employees Doctor of Neurosurgery at Neurological Institute:“The introduction of this novel stroke technology in our region enhances our ability to treat complex arteriography and shows our ongoing commitment to our patients to bring the latest medical progress. This technique is combined with our multi-disciplinary approach to the patient’s care, it is ensured that we provide world-level treatment options for our already, our patient Aggressive treatment option. Dr. Zahra also emphasized long -term capacity:“This technique acts as a springboard for further innovation in our region. By combining our experience with new technology, we will inform the future research initiatives, possibly leading to even more sophisticated treatment methods for complex cerebrovascular conditions. Also, as we collect long -term data on the results of the patient, we expect global neurosurgical communities, we expect global neurosurgical communities. Are, which is in the position of clear clind, region. “

Recognition and impact in the entire region

Health Department – Abu Dhabi (DOH) has formally recognized Cleveland Clinic Abu Dhabi as the center of excellence for stroke care, and has strengthened the regional leadership of the hospital in special treatment routes. Dr, Executive Director of Healthcare Quality Sector in Doh. Fayza Al Yafi commented on the importance of this development:“The Center of Excellence in Abu Dhabi continues to confirm its commitment to enhance the healthcare system by providing special care and using advanced infrastructure of Emirates. Abu Dhabi’s continuous growth and talent in the dynamic regulator environment of Abu Dhabi encourages research and innovation, which congratulates the cutting-flexel. I am ready to work together to give a situation to the healthcare system. This milestone not only reflects a technological success, but is also a result of continuous collaboration between Cleveland Clinic and Mubadala Investment Company. Their long -term partnership has enabled a level of care within the UAE that reduces the requirement of patients to seek complex treatment abroad.

Creation of inheritance of innovation

Established in 2006 through a partnership agreement, Cleveland Clinic Abu Dhabi was conceived as a transformative step in the healthcare distribution for the region. After a careful plan of nearly a decade, this feature officially opened its doors in May 2015. More than 300 physicians and clinical staff worked in collaboration with architects, designers and planners around the world to shape the hospital’s advanced care environment. Supported by a bold initiative from Abu Dhabi’s government, the hospital was designed to expand the access to significant and complex care services that were previously locally unavailable. Today, Cleveland Clinic Abu Dhabi acts as part of a global body that span:

The official inauguration took place on 3 December 2015, headed by Sheikh Mohammed bin Zayed Al Nahyan, then the prince of Abu Dhabi and Deputy Supreme Commander of the Armed Forces. By launching Artis Intracular Flow Modulator, Cleveland Clinic Abu Dhabi has taken another decisive step towards redefining neurological care in the MENA sector, including a vision for state -of -the -art science, collaborative care and long -term innovation.